Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
James C. Foster
CEOJames C. Foster
Employees
20,100
Employees20,100
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
20,100
Employees20,100

CRL Key Statistics

Market cap
6.83B
Market cap6.83B
Price-Earnings ratio
-213.77
Price-Earnings ratio-213.77
Dividend yield
Dividend yield
Average volume
1.77M
Average volume1.77M
High today
$146.43
High today$146.43
Low today
$138.78
Low today$138.78
Open price
$146.15
Open price$146.15
Volume
1.51M
Volume1.51M
52 Week high
$254.15
52 Week high$254.15
52 Week low
$91.86
52 Week low$91.86

CRL News

Simply Wall St 15h
We Think Charles River Laboratories International, Inc.'s CEO Compensation Package Needs To Be Put Under A Microscope

Key Insights Charles River Laboratories International to hold its Annual General Meeting on 20th of May CEO Jim Foster's total compensation includes salary of...

We Think Charles River Laboratories International, Inc.'s CEO Compensation Package Needs To Be Put Under A Microscope
Seeking Alpha 6d
Charles River extends gains as Evercore upgrades after Q1 beat

Charles River Laboratories (NYSE:CRL) continued to trade higher on Thursday as Evercore ISI upgraded the contract research firm following its better-than-expect...

Charles River extends gains as Evercore upgrades after Q1 beat
Simply Wall St 7d
Charles River Laboratories International First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Charles River Laboratories International ( ) First Quarter 2025 Results Key Financial Results Revenue: US$984.2m (down 2.7% from 1Q 2024). Net income: US$25....

Charles River Laboratories International First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Analyst ratings

70%

of 20 ratings
Buy
25%
Hold
70%
Sell
5%

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.